Francisca Ferrer‐Marín

Assessment and prognostic value of the European LeukemiaNet criteria for clinicohematologic response, resistance, and intolerance to hydroxyurea in polycythemia vera

Alberto Álvarez‐Larrán, Arturo Pereira, Francisco Cervantes et al. · Blood · 2011 · 221 citations · Full text

Antiplatelet therapy versus observation in low-risk essential thrombocythemia with a CALR mutation

Alberto Álvarez‐Larrán, Arturo Pereira, Paola Guglielmelli et al. · Haematologica · 2016 · 145 citations · Full text

Developmental differences in megakaryocytopoiesis are associated with up-regulated TPO signaling through mTOR and elevated GATA-1 levels in neonatal megakaryocytes

Zhi-Jian Liu, Joseph E. Italiano, Francisca Ferrer‐Marín et al. · Blood · 2011 · 105 citations · Full text

Frequency and prognostic value of resistance/intolerance to hydroxycarbamide in 890 patients with polycythaemia vera

Alberto Álvarez‐Larrán, Ana Kerguelen, Juan Carlos Hernández‐Boluda et al. · British Journal of Haematology · 2015 · 77 citations · Full text

Pharmacotherapy, Logistic Analysis, Myeloid Neoplasia +17

Busulfan in patients with polycythemia vera or essential thrombocythemia refractory or intolerant to hydroxyurea

Alberto Álvarez‐Larrán, Luz Martínez‐Avilés, Juan Carlos Hernández‐Boluda et al. · Annals of Hematology · 2014 · 76 citations

Thrombosis, Polycythemia Vera, Essential Thrombocythemia Refractory +4